05.12.2023 13:17:19
|
CVS Health Reiterates FY23 Guidance, Issues FY24 Outlook
(RTTNews) - CVS Health Corp.(CVS) Tuesday reiterated its guidance for fiscal 2023 and issued an outlook for fiscal 2024.
The company continues to expect earnings per share in the range of $6.37 to $6.61 and adjusted earnings per share in the range of $8.50 to $8.70 for the full year.
Total revenues are still expected to be between $351.5 billion to $357.3 billion.
Looking forward to fiscal 2024, the company expects at least $7.26 earnings per share and Adjusted EPS of at least $8.50.
Total revenues of at least $366.0 billion are anticipated by the healthcare firm.
Additionally, CVS declared a quarterly dividend of 0.665 cents per share higher by around 10 percent from 0.605 cents per share for the same period last year. The dividend is payable on February 1, 2024, to shareholders of record on January 22, 2023.
In pre-market activity, CVS shares are trading at $69.89, up 2.06% on the New York Stock Exchange.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu CVS Health Corpmehr Nachrichten
16:03 |
S&P 500-Papier CVS Health-Aktie: So viel Verlust hätte eine Investition in CVS Health von vor 5 Jahren bedeutet (finanzen.at) | |
18.12.24 |
Börse New York: So performt der S&P 500 am Mittwochnachmittag (finanzen.at) | |
18.12.24 |
S&P 500-Handel aktuell: S&P 500 verbucht am Mittag Gewinne (finanzen.at) | |
18.12.24 |
Pluszeichen in New York: S&P 500 startet in der Gewinnzone (finanzen.at) | |
17.12.24 |
Dienstagshandel in New York: S&P 500 präsentiert sich zum Handelsende leichter (finanzen.at) | |
17.12.24 |
Börse New York: S&P 500 liegt nachmittags im Minus (finanzen.at) | |
16.12.24 |
Börse New York in Grün: S&P 500 klettert zum Ende des Montagshandels (finanzen.at) | |
13.12.24 |
S&P 500-Wert CVS Health-Aktie: So viel Verlust hätte eine CVS Health-Investition von vor 3 Jahren eingebracht (finanzen.at) |